Investigating Ganglion Cell Complex Thickness in Children with Chronic Heart Failure due to Dilated Cardiomyopathy

Klaudia Rakusiewicz1, Krystyna Kanigowska1, Wojciech Hautz1

  • 1Department of Ophthalmology, Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Journal of Clinical Medicine
|September 10, 2020
PubMed

Insights

This study found no significant differences in ganglion cell complex thickness in children with chronic heart failure (CHF) due to dilated cardiomyopathy (DCM) compared to healthy children. Optical coherence tomography (OCT) revealed no changes in these key retinal measurements.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Pediatrics

Background:

  • Chronic heart failure (CHF) in children, often due to dilated cardiomyopathy (DCM), can have systemic effects.
  • Assessing ocular health in pediatric patients with CHF is crucial for comprehensive care.

Purpose of the Study:

  • To evaluate ganglion cell complex (GCC) thickness in pediatric patients with CHF/DCM using optical coherence tomography (OCT).
  • To compare GCC parameters between children with CHF/DCM and healthy controls.

Main Methods:

  • Sixty eyes from 30 pediatric patients with CHF/DCM and 60 eyes from 30 healthy children were analyzed.
  • Optical coherence tomography (OCT) was used to measure average GCC (avgGCC), superior GCC (supGCC), inferior GCC (infGCC), global loss of volume (GLV), and focal loss of volume (FLV).
  • Statistical analysis compared parameters between the CHF/DCM group and the control group, and explored correlations with clinical factors.

Main Results:

  • No significant differences were found in avgGCC, supGCC, infGCC, GLV, or FLV between children with CHF/DCM and healthy controls.
  • No correlations were observed between GCC parameters and ocular biometry, refractive errors, age, NT-proBNP, or LVEF.
  • No significant differences were noted based on sex or between the left and right eyes.

Conclusions:

  • This study, the first of its kind, indicates no alterations in GCC thickness in pediatric patients with DCM-related CHF.
  • The findings suggest that GCC thickness may not be a sensitive indicator of cardiac dysfunction in this specific pediatric population.
  • Further research may explore other ocular parameters or different etiologies of pediatric heart failure.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
236
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
517
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
280
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
307
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K